Anthelmintic Combination of 2-Desoxoparaherquamide and Abamectin
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anthelmintic treatments face challenges with resistance development and limited spectrum of activity against parasitic infections, necessitating the need for novel combinations that can effectively target a wide range of parasites, including those resistant to macrocyclic lactones.
Innovation Solution
A combination of 2-desoxoparaherquamide and abamectin is administered simultaneously or sequentially to mammals to treat parasitic infestations, offering a novel anthelmintic composition that can be used as a medicament to control a broad spectrum of parasites, including those resistant to macrocyclic lactones.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional anthelmintic treatments are used, then treatment simplicity is maintained, but parasite resistance develops and spectrum of activity is limited
Solution Approach 1:
The patent combines two anthelmintic agents with different mechanisms of action: a spirodioxepinoindole (paraherquamide derivative) and a macrocyclic lactone (abamectin). This combination approach allows the treatment to maintain effectiveness against parasites resistant to either single agent, thereby expanding the spectrum of activity while preventing resistance development through multiple simultaneous targets
Solution Approach 2:
The invention creates a composite anthelmintic formulation containing both spirodioxepinoindole and macrocyclic lactone compounds. This composite approach integrates two different chemical classes with complementary antiparasitic properties, enabling broader coverage against diverse parasite species and resistance mechanisms while maintaining treatment reliability
2Adaptability or versatility
If novel anthelmintic agents are developed, then resistance is reduced and spectrum is widened, but treatment complexity increases
Solution Approach 1:
The patent merges two anthelmintic agents into a single combined treatment formulation, allowing simultaneous administration of both spirodioxepinoindole and macrocyclic lactone. This unified approach delivers the benefits of dual-mechanism action without requiring separate treatment protocols, thereby managing complexity while maintaining expanded spectrum of activity
Data Source
AI summary
A method is provided for the treatment of parasitic infestations in mammals, comprising the step of simultaneously or sequentially administering to the mammal effective amounts of (a) 2-desoxoparaherquamide; and (b) abamectin. Also provided is an anthelmintic composition comprising 2-desoxoparaherquamide and abamectin.